<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.36485/1561-6274-2020-24-1-45-50</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-1789</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. CLINICAL INVESTIGATIONS</subject></subj-group></article-categories><title-group><article-title>Особенности фосфорно-кальциевого обмена у детей с нейрогенными расстройствами мочеиспускания</article-title><trans-title-group xml:lang="en"><trans-title>Features of phosphorus-calcium metabolism in children with neurogenic disorders of urination</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6284-1604</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лобанов</surname><given-names>Ю. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Lobanov</surname><given-names>Yu. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Профессор Лобанов Юрий Федорович, доктор медицинских наук, кафедра пропедевтики детских болезней, заведующий</p><p>656038, г. Барнаул, пр. Ленина, д. 40</p></bio><bio xml:lang="en"><p>Prof. Yuri F. Lobanov, MD, PhD, DMedSci, Department of Pediatric Diseases Propedeutics</p><p>656038, Barnaul, Lenina st. 40</p></bio><email xlink:type="simple">ped2@agmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0014-2581</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Латышев</surname><given-names>Д. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Latyshev</surname><given-names>D. Y.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доцент Латышев Дмитрий Юрьевич, кандидат медицинских наук, кафедра пропедевтики детских болезней</p><p>656038, г. Барнаул, пр. Ленина, д. 40</p></bio><bio xml:lang="en"><p>Associate Prof Dmitry Y. Latyshev. MD, PhD, Department of Pediatric Diseases Propedeutics</p><p>656038, Barnaul, Lenina st. 40</p></bio><email xlink:type="simple">ldy2014@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8101-103X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зверев</surname><given-names>Я. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Zverev</surname><given-names>Ya. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Профессор Зверев Яков Федорович, доктор медицинских наук, кафедра фармакологии</p><p>656038, г. Барнаул, пр. Ленина, д. 40</p></bio><bio xml:lang="en"><p>Prof. Yakov F. Zverev, MD, PhD, DMedSci, Department of Pharmacology</p><p>656038, Barnaul, Lenina st. 40</p></bio><email xlink:type="simple">zver@asmu.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1878-7502</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Текутьева</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tekuteva</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Текутьева Надежда Анатольевна, кафедра пропедевтики детских болезней</p><p>656038, г. Барнаул, пр. Ленина, д. 40</p></bio><bio xml:lang="en"><p>Nadezhda A. Tekuteva, MD, Department of Pediatric Diseases Propedeutics</p><p>656038, Barnaul, Lenina st. 40</p></bio><email xlink:type="simple">tekuteva.n@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0944-5949</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Михеева</surname><given-names>Н. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikheeva</surname><given-names>N. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доцент Михеева Наталия Михайловна, кандидат медицинских наук, кафедра пропедевтики детских болезней</p><p>656038, г. Барнаул, пр. Ленина, д. 40</p></bio><bio xml:lang="en"><p>Associate Prof. Natalya M. Mikheeva MD, PhD, Department of Pediatric Diseases Propedeutics</p><p>656038, Barnaul, Lenina st. 40</p></bio><email xlink:type="simple">micheeva.1974@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Алтайский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Altai State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>23</day><month>01</month><year>2020</year></pub-date><volume>24</volume><issue>1</issue><fpage>45</fpage><lpage>50</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лобанов Ю.Ф., Латышев Д.Ю., Зверев Я.Ф., Текутьева Н.А., Михеева Н.М., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Лобанов Ю.Ф., Латышев Д.Ю., Зверев Я.Ф., Текутьева Н.А., Михеева Н.М.</copyright-holder><copyright-holder xml:lang="en">Lobanov Y.F., Latyshev D.Y., Zverev Y.F., Tekuteva N.A., Mikheeva N.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/1789">https://journal.nephrolog.ru/jour/article/view/1789</self-uri><abstract><sec><title></title><p>.</p></sec><sec><title>ПАЦИЕНТЫ И МЕТОДЫ</title><p>ПАЦИЕНТЫ И МЕТОДЫ. В исследование включено 90 детей, из них 60 детей с нейромышечной дисфункцией мочевого пузыря (НМДМП) и 30 детей с энурезом в возрасте от 5 до 15 лет. Диагноз устанавливали на основании данных комплексного обследования и согласно отраслевым стандартам. Дисплазию соединительной ткани диагностировали у детей при выявлении 6 и более малых внешних или висцеральных проявлений с вовлечением 3 и более органов из разных систем. Оценка степени выраженности (тяжести) дисплазии соединительной ткани проводилась по балльной системе, предложенной Т.И. Кадуриной и др. Каждую группу разделили на подгруппы в зависимости от выраженности проявлений дисплазии соединительной ткани. Проводили определение уровня кальция и фосфора в крови и моче, а также расчет кальций-креатининового коэффициента с последующим сравнением результатов в указанных группах и подгруппах. Для оценки достоверности различий вычисляли критерий Манна–Уитни, значения р &lt;0,05 рассматривали как значимые. </p></sec><sec><title>РЕЗУЛЬТАТЫ</title><p>РЕЗУЛЬТАТЫ. Уровень кальция и фосфора в моче был несколько выше у детей с энурезом, особенно в утренней порции мочи, где концентрация кальция на 26% превосходила показатель у больных с НМДМП. В то же время, величина кальций/креатининового коэффициента была существенно выше в группе больных с энурезом и в 2 раза превышала нормативные показатели, что свидетельствует о значении гиперкальциурии в развитии энуреза. </p></sec><sec><title>ЗАКЛЮЧЕНИЕ</title><p>ЗАКЛЮЧЕНИЕ: согласно полученным данным, выраженность кальциурии, определяемая по значению кальций-креатининового коэффициента, достоверно выше у больных с энурезом, чем с НМДМП.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>THE AIM</title><p>THE AIM: To study the characteristics of phosphorus-calcium metabolism in patients with neurogenic disorders of urination, taking into account the severity of the manifestations of connective tissue dysplasia. </p></sec><sec><title>PATIENTS AND METHODS</title><p>PATIENTS AND METHODS. The study included 90 children, including 60 children with neuro-muscular dysfunction of the bladder (NMDB) and 30 children with enuresis from the age of 5 to 15 years. The diagnosis was established based on a comprehensive examination and according to industry standards. Connective tissue dysplasia was diagnosed in children with the detection of 6 or more small external or visceral manifestations involving 3 or more organs from different systems. Assessment of the severity (severity) of connective tissue dysplasia was carried out according to the point system proposed by T.I. Kadurina et al. Each group was divided into subgroups depending on the severity of the manifestations of connective tissue dysplasia. The determination of the level of calcium and phosphorus in the blood and urine, as well as the calculation of the calcium-creatinine coefficient followed by a comparison of the results in these groups and subgroups. To assess the significance of differences, the Mann-Whitney test was calculated, p &lt;0.05 was considered significant. </p></sec><sec><title>RESULTS</title><p>RESULTS. he level of calcium and phosphorus in the urine was slightly higher in children with enuresis, especially in the morning portion of urine, where the concentration of calcium was 26% higher than in patients with NMDB. At the same time, the value of calcium /creatinine coefficient was significantly higher in the group of patients with enuresis and was 2 times higher than the normative indicators, which indicates the importance of hypercalciuria in the development of enuresis.</p></sec><sec><title> СONCLUSION</title><p> СONCLUSION. According to the obtained data, the severity of calciuria, determined by the value of the calcium-creatinine coefficient, is significantly higher in patients with enuresis than with NMDB.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>энурез</kwd><kwd>нейромышечная дисфункция мочевого пузыря</kwd><kwd>кальций-креатининовый коэффициент</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Children</kwd><kwd>enuresis</kwd><kwd>neuro-muscular dysfunction of the bladder</kwd><kwd>calcium-creatinine coefficien</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Кадурина ТИ, Горбунова ВН. Дисплазия соединительной ткани. Руководство для врачей. Элби, СПб., 2009; 714</mixed-citation><mixed-citation xml:lang="en">Kadurina TI, Gorbunova VN. Connective tissue dysplasia. Guide for doctors. Elbi, SPb., 2009; 714</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Морозов СЛ, Гусева НБ, Длин ВВ. Перспектива энерготропной терапии нейрогенной дисфункции мочевого пузыря. Российский вестник перинатологии и педиатрии 2013;58(5): 35–38</mixed-citation><mixed-citation xml:lang="en">Morozov SL, Guseva NB, Dlin VV. The prospect of energetic therapy of neurogenic bladder dysfunction. Russian Bulletin of Perinatology and Pediatrics 2013; 58(5): 35–38</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Аляев Ю.Г. Расстройства мочеиспускания. Литтера, М., 2006; 208</mixed-citation><mixed-citation xml:lang="en">Alyayev Yu. G. Urination disorders. Littera, M., 2006; 208</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Heiliczer JD, Canonigo BB, Bishof NA, Moore TS. Noncalculi urinary tract disorders secondary to idiopathic hypercalciuria in children. Pediatr Clin North Am 1987; 34 (3): 711–718</mixed-citation><mixed-citation xml:lang="en">Heiliczer JD, Canonigo BB, Bishof NA, Moore TS. Noncalculi urinary tract disorders secondary to idiopathic hypercalciuria in children. Pediatr Clin North Am 1987; 34 (3): 711–718</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Vachvanichsanong P. Urinary incontinence due to idiopathic hypercalciuria in children /Vachvanichsanong P., Malagon M., Moore E.S. J Urol 1994; 152 (4):1226–1228</mixed-citation><mixed-citation xml:lang="en">Vachvanichsanong P. Urinary incontinence due to idiopathic hypercalciuria in children /Vachvanichsanong P., Malagon M., Moore E.S. J Urol 1994; 152 (4):1226–1228</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Михеева НМ, Зверев ЯФ, Выходцева ГИ. Современные представления об этиологии и патогенезе идиопатической гиперкальциурии. Нефрология 2015;19(4):29–40</mixed-citation><mixed-citation xml:lang="en">Mikheeva NM, Zverev YF, Vykhodceva GI. Modern views on idiopathic hypercalciuria aetiology and pathogenesis. Nephrology (Saint-Petersburg) 2015;19(4):29–40. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Михеева НМ, Выходцева ГИ, Зверев ЯФ, Лобанов ЮФ. Особенности течения идиопатической гиперкальциурии у детей. анализ клинико-лабораторных проявлений. Нефрология 2017;21(4):68–72. https://doi.org/10.24884/1561-6274-201721-4-68-72</mixed-citation><mixed-citation xml:lang="en">Mikheeva NM, Vykhodtseva GI, Zverev YF, Lobanov YF. Features of the course of idiopathic hypercalciuria in children. analysis of clinical and laboratory manifestations. Nephrology (Saint-Petersburg) 2017;21(4):68–72. (In Russ.) https://doi. org/10.24884/1561-6274-2017-21-4-68-72</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Parekh DJ, Pope JC, Adams MC, Brock JW. The role of hypercalciuria in a subgroup of dysfunctional voiding syndromes of childhood. J Urol 2000; 164(3), Pt. 2:1008–1010</mixed-citation><mixed-citation xml:lang="en">Parekh DJ, Pope JC, Adams MC, Brock JW. The role of hypercalciuria in a subgroup of dysfunctional voiding syndromes of childhood. J Urol 2000; 164(3), Pt. 2:1008–1010</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Fallahzadeh MK, Fallahzadeh MH, Mowla A et al. Hyper-calciuria in children with urinary tract symptoms. Saudi J Kidney Dis Transpl 2010;21(4): 673–677</mixed-citation><mixed-citation xml:lang="en">Fallahzadeh MK, Fallahzadeh MH, Mowla A et al. Hyper-calciuria in children with urinary tract symptoms. Saudi J Kidney Dis Transpl 2010;21(4): 673–677</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Derakhshan A. Hypercalciuria in children with urinary tract symptoms. Saudi J Kidney Dis Transpl 2010; 21(4):673–674</mixed-citation><mixed-citation xml:lang="en">Derakhshan A. Hypercalciuria in children with urinary tract symptoms. Saudi J Kidney Dis Transpl 2010; 21(4):673–674</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Nikibakhsh A, Poostindooz H, Mahmoodzadeh H et al. Is there any correlation between hypercalciuria and nocturnal enuresis? Indian J Nephrol 2012;22(2):88–93</mixed-citation><mixed-citation xml:lang="en">Nikibakhsh A, Poostindooz H, Mahmoodzadeh H et al. Is there any correlation between hypercalciuria and nocturnal enuresis? Indian J Nephrol 2012;22(2):88–93</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Земцовский ЭВ. Соединительнотканные дисплазии сердца. ТОО «Политекс–Норд–Вест», СПб., 2000; 115</mixed-citation><mixed-citation xml:lang="en">Zemtsovskiy E.V. Connective tissue dysplasia of the heart. TOO «Politeks–Nord–Vest», SPb., 2000; 115</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Творогова ТМ, Воробьева АС. Недифференцированная дисплазия соединительной ткани с позиций дизэлементоза у детей и подростков. Русский медицинский журнал 2012; (24):1215–1221.</mixed-citation><mixed-citation xml:lang="en">Tvorogova TM, Vorob'eva AS. Undifferentiated connective tissue dysplasia from the position of dyselementosis in children and adolescents. Russian medical journal 2012; (24):1215–1221.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
